BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4050223)

  • 21. Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis. A pilot study.
    Farina C; Wagenpfeil S; Hohlfeld R
    J Neurol; 2002 Nov; 249(11):1587-92. PubMed ID: 12420101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The comparison of the effectiveness of treatment of multiple sclerosis relapse with high doses of methylprednisolone, alpha-24 corticotropin and cyclophosphamide].
    Paradowski B; Gruszka E; Pokryszko A
    Pol Merkur Lekarski; 1999 Jun; 6(36):305-7. PubMed ID: 10481540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytochemical characteristics of nucleic acids in the peripheral blood lymphocytes of patients with multiple sclerosis].
    Grechukh AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):672-4. PubMed ID: 936868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modifications of the lipid metabolism induced by interferon beta in multiple sclerosis patients and its relationship with the disease activity].
    Ara JR; López A; Martín J; Alarcia R; Oliván JA; de Val V
    Neurologia; 2004 Sep; 19(7):359-63. PubMed ID: 15273882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Amino acid determinations in the serum of patients with multiple sclerosis (author's transl)].
    Kisser W
    Wien Klin Wochenschr; 1974 Feb; 86(3):80-2. PubMed ID: 4439940
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of nicotinamide supplementation on liver and serum contents of amino acids in diabetic rats.
    Kuchmerovska T; Shymanskyy I; Bondarenko L; Klimenko A
    Eur J Med Res; 2008 Jun; 13(6):275-80. PubMed ID: 18558553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of multiple sclerosis with beta-interferon 1a].
    Rivera VM
    Rev Neurol; 2000 Sep 1-15; 31(5):470-1. PubMed ID: 11027100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of constipation in multiple sclerosis].
    Gürtler J
    Ther Umsch; 1967 Feb; 24(2):73-4. PubMed ID: 5595194
    [No Abstract]   [Full Text] [Related]  

  • 29. Perceptive deafness treated with vitamin B-complex and amino acids; 100 cases.
    CHILDREY JH
    Laryngoscope; 1954 Feb; 64(2):120-2. PubMed ID: 13131895
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of Nutrimade in hypoalbuminemia].
    Pozuelo A
    Rev Clin Esp; 1971 Mar; 120(6):557-62. PubMed ID: 5164800
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the effects of different carbohydrate administration on plasma free amino acids in relation to blood glucose and plasma insulin responses in abdominal surgery.
    Akamatsu T; Ohba M; Narahara N; Kodaira S; Maruta M; Mimura T; Uekusa M
    Z Ernahrungswiss Suppl; 1971; 11():58-70. PubMed ID: 5003381
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of polyamine and prostaglandins on the organ-tissue metabolism of the gastrointestinal tract during parenteral feeding].
    Glants RM; Iakovenko AN; Liubinets LA; Parobetskaia IM
    Probl Gematol Pereliv Krovi; 1982 May; 27(5):41-7. PubMed ID: 6808501
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of Lyell's syndrome not due to the administration of drugs].
    Altobella L
    Arch Ital Dermatol Venereol Sessuol; 1969; 35(6):469-75. PubMed ID: 4393758
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of complex treatment including casein hydrolysate and vitamin U on the protein-amino acid spectrum of the blood in patients with peptic ulcer].
    Ilika VG
    Ter Arkh; 1974; 46(9):99-103. PubMed ID: 4439313
    [No Abstract]   [Full Text] [Related]  

  • 35. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
    Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
    Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.
    Kopff M; Zakrzewska I; Klem J; Puczkowski S; Strzelczyk M; Czernicki J; Chmielewski H
    Pol J Pharmacol; 1995; 47(6):525-30. PubMed ID: 8868375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFNbeta therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis.
    García-Merino A; Barcenilla H; Díaz D; Monserrat J; Prieto A; Alvarez-Mon M;
    Clin Immunol; 2009 Aug; 132(2):195-202. PubMed ID: 19443275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oral supplementation of free amino acids in type 2 diabetic patients-- a pilot clinical trial.
    Natarajan Sulochana K; Lakshmi S; Punitham R; Arokiasamy T; Sukumar B; Ramakrishnan S
    Med Sci Monit; 2002 Mar; 8(3):CR131-7. PubMed ID: 11887024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience with the clinical use of a complex of amino acids and anabolic preparations in treating peptic ulcer patients].
    Trusov VV; Vakhrushev IaM
    Ter Arkh; 1984; 56(2):52-5. PubMed ID: 6710406
    [No Abstract]   [Full Text] [Related]  

  • 40. [Concentration of free amino acids in the blood and urine during radiotherapy].
    Tiutin LA
    Med Radiol (Mosk); 1968 Oct; 13(10):21-6. PubMed ID: 5742321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.